Adaptimmune Therapeutics plc Stock Price (Quote) NASDAQ:ADAP
$2.10 ( 4.48% ) Friday, 2nd Dec 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.41 | $2.64 | Friday, 2nd Dec 2022 ADAP stock ended at $2.10. This is 4.48% more than the trading day before Thursday, 1st Dec 2022. During the day the stock fluctuated 8.95% from a day low at $1.96 to a day high of $2.13. |
| 90 days | $1.01 | $2.64 | |
| 52 weeks | $1.01 | $4.17 |
Historical Adaptimmune Therapeutics plc prices
| Date | Open | High | Low | Close | Volume |
| 2022-12-02 | $2.00 | $2.13 | $1.96 | $2.10 | 507 007 |
| 2022-12-01 | $2.15 | $2.18 | $2.01 | $2.01 | 179 501 |
| 2022-11-30 | $2.25 | $2.38 | $2.20 | $2.25 | 207 721 |
| 2022-11-29 | $2.15 | $2.28 | $2.10 | $2.18 | 384 344 |
| 2022-11-28 | $2.20 | $2.30 | $2.11 | $2.13 | 209 781 |
| 2022-11-25 | $2.26 | $2.40 | $2.19 | $2.20 | 152 004 |
| 2022-11-23 | $2.41 | $2.52 | $2.18 | $2.22 | 385 535 |
| 2022-11-22 | $2.54 | $2.54 | $2.30 | $2.38 | 450 295 |
| 2022-11-21 | $2.31 | $2.54 | $2.30 | $2.51 | 373 311 |
| 2022-11-18 | $2.42 | $2.43 | $2.32 | $2.37 | 302 237 |
| 2022-11-17 | $2.21 | $2.37 | $2.20 | $2.35 | 276 107 |
| 2022-11-16 | $2.37 | $2.38 | $2.24 | $2.35 | 669 278 |
| 2022-11-15 | $2.51 | $2.61 | $2.32 | $2.46 | 533 786 |
| 2022-11-14 | $2.52 | $2.64 | $2.43 | $2.63 | 1 038 435 |
| 2022-11-11 | $2.30 | $2.57 | $2.28 | $2.50 | 819 841 |
| 2022-11-10 | $2.10 | $2.25 | $2.03 | $2.25 | 599 945 |
| 2022-11-09 | $2.20 | $2.27 | $2.04 | $2.11 | 1 356 912 |
| 2022-11-08 | $1.78 | $2.15 | $1.70 | $2.08 | 1 457 606 |
| 2022-11-07 | $1.63 | $1.71 | $1.57 | $1.66 | 294 142 |
| 2022-11-04 | $1.62 | $1.64 | $1.56 | $1.60 | 391 361 |
| 2022-11-03 | $1.50 | $1.63 | $1.46 | $1.59 | 255 321 |
| 2022-11-02 | $1.47 | $1.53 | $1.41 | $1.51 | 197 241 |
| 2022-11-01 | $1.44 | $1.50 | $1.41 | $1.45 | 355 199 |
| 2022-10-31 | $1.38 | $1.45 | $1.38 | $1.42 | 187 763 |
| 2022-10-28 | $1.34 | $1.41 | $1.33 | $1.39 | 224 158 |
| 2022-10-27 | $1.36 | $1.40 | $1.30 | $1.37 | 256 275 |
| 2022-10-26 | $1.23 | $1.36 | $1.22 | $1.34 | 597 700 |
| 2022-10-25 | $1.03 | $1.27 | $1.02 | $1.27 | 833 528 |
| 2022-10-24 | $1.28 | $1.28 | $1.18 | $1.20 | 729 913 |
| 2022-10-21 | $1.32 | $1.41 | $1.26 | $1.28 | 4 925 066 |
| 2022-10-20 | $1.24 | $1.42 | $1.22 | $1.31 | 448 851 |
| 2022-10-19 | $1.16 | $1.25 | $1.14 | $1.23 | 479 446 |
| 2022-10-18 | $1.14 | $1.22 | $1.14 | $1.17 | 146 242 |
| 2022-10-17 | $1.13 | $1.22 | $1.09 | $1.16 | 225 319 |
| 2022-10-14 | $1.12 | $1.17 | $1.09 | $1.13 | 143 540 |
| 2022-10-13 | $1.05 | $1.13 | $1.02 | $1.12 | 172 293 |
| 2022-10-12 | $1.08 | $1.09 | $1.03 | $1.05 | 153 280 |
| 2022-10-11 | $1.08 | $1.18 | $1.03 | $1.09 | 212 601 |
| 2022-10-10 | $1.19 | $1.19 | $1.08 | $1.09 | 469 682 |
| 2022-10-07 | $1.13 | $1.23 | $1.06 | $1.20 | 616 776 |
| 2022-10-06 | $1.12 | $1.16 | $1.08 | $1.12 | 196 887 |
| 2022-10-05 | $1.14 | $1.16 | $1.09 | $1.10 | 313 986 |
| 2022-10-04 | $1.09 | $1.20 | $1.08 | $1.15 | 274 235 |
| 2022-10-03 | $1.05 | $1.16 | $1.03 | $1.08 | 332 799 |
| 2022-09-30 | $1.08 | $1.09 | $1.01 | $1.08 | 317 128 |
| 2022-09-29 | $1.15 | $1.16 | $1.02 | $1.06 | 597 620 |
| 2022-09-28 | $1.10 | $1.19 | $1.09 | $1.15 | 528 532 |
| 2022-09-27 | $1.20 | $1.24 | $1.09 | $1.11 | 584 206 |
| 2022-09-26 | $1.16 | $1.24 | $1.16 | $1.20 | 270 213 |
| 2022-09-23 | $1.35 | $1.40 | $1.10 | $1.17 | 1 155 076 |
About Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
